CDKN2A and neoplasm: Among them, 171 (96.6%) tumors showed immunoreactive neoplastic cells in each tumor core, whereas heterogeneous p16Ink4A expression across tumor cores was restricted to 6 (3.4%) cases, namely 5 ADCs and 1 SCC, as detailed in Table 3.